Technology | Ultrasound Women's Health | September 30, 2016

Hitachi Aloka Medical America and iVu Pair Ultrasound Technologies for Whole-breast Imaging

Hitachi’s Arietta 60 and Arietta 70 systems now integrate iVu’s whole-breast imaging system

Hitachi Aloka Medical America, Arietta ultrasound, iVu, Sofia whole-breast imaging system, RSNA 2016

September 30, 2016 — Hitachi Aloka Medical America recently announced the support of its Arietta 70 and Arietta 60 ultrasound systems with iVu Imaging Corp.’s Sofia 3-D whole-breast imaging system. The Hitachi Arietta platform and its long linear transducer enable the Sofia system to automate the 3-D radial acquisition of an entire breast in nearly half the time of previous-generation ultrasound systems.

David Famiglietti, president of Hitachi Aloka Medical America, explained that pairing Arietta with Sofia improves the image quality and speed of whole-breast exams. The combination allows scan times of 30 seconds per breast, enabling a bilateral whole-breast study to be scheduled every 10 minutes.

Famiglietti also highlighted Sofia’s convertible scan table that allows it to support a broad spectrum of conventional manual ultrasound exams when it is not being used for whole-breast imaging.

Mark Stribling, president of iVu, noted “The Arietta platform is the latest in a series of game-changing breakthroughs for 3-D whole-breast ultrasound. Hitachi ultrasound now enables the Sofia system to scan eight times faster than its original configuration, while also tripling the resolution.” Stribling added, “At the same time, we are still able to present a single breast volume to the radiologist, clearly showing the structures of the breast in their natively-acquired radial plane along with the reconstructed coronal, sagittal, and oblique views if desired. The result is average interpretation times of about one minute per breast.”

Hitachi Aloka Medical America stated that it will begin shipping Sofia-capable Arietta 70 and Arietta 60 systems in the United States in September and will offer a software upgrade to existing Arietta 70 and Arietta 60 customers shortly thereafter.

For more information: www.hitachi-aloka.com, www.ivuimaging.com

Related Content

A recent study earlier this year in the journal Nature, which included researchers from Google Health London, demonstrated that artificial intelligence (AI) technology outperformed radiologists in diagnosing breast cancer on mammograms
Feature | Breast Imaging | April 06, 2020 | By Samir Parikh
A recent study earlier this year in the journal Nature,
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Sonogram taken under rib cage shows liver (grey) with curved diaphragm-lung border (white). Arrows point to vertical B lines (white) demonstrating diseased lung tissue. The more B lines the worse the disease. Healing is measured by reduction in the number of B lines.

Sonogram taken under rib cage shows liver (grey) with curved diaphragm-lung border (white). Arrows point to vertical B lines (white) demonstrating diseased lung tissue. The more B lines the worse the disease. Healing is measured by reduction in the number of B lines.

News | Coronavirus (COVID-19) | April 06, 2020
April 6, 2020 — Robert L.
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
Feature | Breast Density | April 03, 2020 | By Dayna Williams M.D., Shivani Chaudhry, M.D., and Laurie R. Margolies, M.D.
Breast cancer is the most common cance
An estimated 44 million people worldwide are currently living with Alzheimer’s disease, the most common form of dementia. About 5.8 million people in the United States live with the disease, where it is the sixth leading cause of death overall. While there is not yet a cure for Alzheimer’s, researchers are working to find treatment options to delay its onset and prevent it from developing.

Image courtesy of Insightec

Feature | Ultrasound Imaging | April 02, 2020 | By Katie Caron
An estimated 44 million people worldwide are currently living with...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

News | Ultrasound Imaging | April 02, 2020
April 2, 2020 — Esaote, an Italian company among the world leader
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Mammography | March 25, 2020
March 25, 2020 — The...
The 2020 Society of Breast Imaging/American College of Radiology (SBI/ACR) annual symposium has been cancelled, and the event rescheduled for April 8-11, 2020, in Savannah, Ga. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SBI20
News | Society of Breast Imaging (SBI) | March 16, 2020
March 16, 2020 — The 2020 Society of Breast Imaging/American College of Radiology (...
DBT, sometimes called 3-D mammography, emerged in the last decade as a powerful tool for breast cancer screening

Images in a 57-year-old woman noted to have "good prognosis" invasive cancer detected at digital breast tomosynthesis (DBT) screening. (a) Craniocaudal view of the left breast obtained with the two-dimensional digital mammography (DM) portion of the DM/DBT screening study demonstrates a subtle area of distortion in the medial left breast. (b) Single-slice image from the left craniocaudal DBT portion of the screening study shows an area of bridging distortion (circle). (c) Electronically enlarged image of the area of concern seen on the left craniocaudal view in a single DBT slice as shown in b. (d) Targeted US scan demonstrates two small adjacent irregular solid masses. US-guided core biopsy yielded an invasive carcinoma of the tubular subtype that was estrogen receptor positive, progesterone receptor positive, and human epidermal growth factor receptor 2 negative. The results of the sentinel node biopsy were negative. Image courtesy of the Radiological Society of North America

News | Breast Imaging | March 11, 2020
March 11, 2020 — A new study published in the journal ...